131: Calcium replacement may be harmful, sulfamethoxazole-trimethoprim dosing in morbid obesity, and a resource for switching to anti-XA heparin monitoring

Show notes at pharmacyjoe.com/episode131.

In this episode I’ll:

1. Discuss an article about the adverse outcomes of calcium administration in critically ill patients.

2. Answer the drug information question “What dose of sulfamethoxazole/trimethoprim should be used to treat stenotrophomonas in a super-morbidly obese patient?”

3. Share a resource I’ve used to convert heparin protocols to anti-Xa monitoring.